These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25790374)

  • 1. Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients.
    Agarwal G; Vasquez K; Penagaluru N; Gelfond J; Qunibi WY
    Hemodial Int; 2015 Oct; 19(4):499-508. PubMed ID: 25790374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
    Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
    Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients.
    Agarwal G; Hirachan P; Gelfond J; Fanti P; Hura C; Bansal S
    BMC Nephrol; 2016 Oct; 17(1):144. PubMed ID: 27717322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events.
    Lishmanov A; Dorairajan S; Pak Y; Chaudhary K; Chockalingam A
    Am J Ther; 2013; 20(5):480-6. PubMed ID: 22185755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
    Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
    Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen.
    Porter A; Gilmartin C; Srisakul U; Arruda J; Akkina S
    Am J Nephrol; 2013; 37(6):568-74. PubMed ID: 23735861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
    Qunibi WY; Abdellatif A; Sankar S; Hamdan Z; Lin FY; Ingle J; Cadena A; Gelfond J; Kasinath B
    Clin Nephrol; 2010 Apr; 73(4):276-85. PubMed ID: 20353735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
    Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
    Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly high-dose ergocalciferol to correct vitamin D deficiency/insufficiency in hemodialysis patients: a pilot trial.
    Del Valle E; Negri AL; Fradinger E; Canalis M; Bevione P; Curcelegui M; Bravo M; Puddu M; Marini A; Ryba J; Peri P; Rosa Diez G; Sintado L; Gottlieb E
    Hemodial Int; 2015 Jan; 19(1):60-5. PubMed ID: 25231816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
    Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO
    J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D status of children receiving chronic dialysis.
    Dibas BI; Warady BA
    Pediatr Nephrol; 2012 Oct; 27(10):1967-73. PubMed ID: 22660955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study.
    Daroux M; Shenouda M; Bacri JL; Lemaitre V; Vanhille P; Bataille P
    J Nephrol; 2013; 26(1):152-7. PubMed ID: 22641581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.
    Dreyer G; Tucker AT; Harwood SM; Pearse RM; Raftery MJ; Yaqoob MM
    PLoS One; 2014; 9(7):e99461. PubMed ID: 25006678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients.
    Bashardoust B; Zakeri A; Fouladi N; Izadi Z; Hosseini F
    Iran J Kidney Dis; 2018 Nov; 12(6):359-363. PubMed ID: 30595565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.